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Color DopplerAbstract Objectives: To evaluate diagnostic yield of mammography, B-mode ultrasound (US),
ultrasound elastography (UE) and color Doppler used alone or in combination for differentiating
breast lesions.
Patients and methods: Sixty women presented by breast lump underwent mammographic examina-
tion, B-mode US, color Doppler assessment and UE. The result of histopathological examination of
excisional biopsy was used as gold standard for comparison of results.
Results: Mammography deﬁned 36 patients had dense glandular breast and 24 patients had fatty
parenchyma. Eleven patients had dense glandular parenchyma and 7 of those had fatty parenchyma
had malignant lesions. Mean resistive index for malignant lesions was signiﬁcantly higher than
benign lesions. The mean strain ratio was signiﬁcantly higher for malignant. Combined use of
US and UE provided better diagnostic yield than US and Doppler, while combined use of US,
UE and Doppler improved the diagnostic yield with high sensitivity and speciﬁcity and NPV of
95%. ROC curve analysis assured the high diagnostic yield of combination of US, UE and Doppler.
Conclusion: Combined use of B-mode US, UE and color Doppler achieved NPV of 95% thus
allowed sparing of unnecessary invasive diagnostic procedures. UE as a sole diagnostic test has high
sensitivity and speciﬁcity. Mammography could be used as screening test for its high sensitivity.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Breast cancer remains a worldwide public health problem. It is
considered to be the primary women’s cancer and causes high
morbidity and mortality that aroused attention for disease pre-
ventive programs. Multiple cross-sectional studies indicated
the effectiveness of chemo-preventive measures for breast can-
cer in high risk women. The relative risk reduction seems sim-
ilar across all breast cancer risk groups; however, the absolute
1232 A. Elkharbotly, H.M. Faroukrisk reduction varies by risk factors for breast cancer and must
be balanced against the potential harms to judge the appropri-
ateness of treatment for individual women (1–4).
The debit about the adequacy of chemo-preventive pro-
grams deviated attention toward early detection programs
starting with breast self-examination for early detection of
changes occurring in the breast and ending with mass-screen
surveys. Knowledge of women about the risks and beneﬁts
of early detection of breast cancer positively affects their
health beliefs, attitudes, and behaviors. Health care profession-
als can develop effective breast health programs and can help
women to gain good health behavior and to maintain health
(5–7).
Breast ultrasonography (US) plays a critical role in the
diagnostic evaluation of screening-detected or palpable breast
masses. US with a high-frequency transducer is essential for
accurate noninvasive diagnosis of breast cysts and is the
method of choice for differentiating solid from cystic lesions.
In addition, US has been advocated and shown to be poten-
tially useful in the examination of young or pregnant symp-
tomatic patients. Ultrasound has shown promise in the
differentiation of benign from malignant solid masses. Breast
ultrasound is the preferable screening method as it provides
high sensitivity for detecting breast cancer in women with
dense breast tissue and can detect cancers not identiﬁed on
mammography in asymptomatic women with dense breast tis-
sue. Incremental US cancer detection is reported in 0.27–
0.46% of women with mammography-negative dense breasts
(8,9).
Degree of lack of the strain of a focal lesion in breast elas-
tography is an important ﬁnding which improves the diagnos-
tic reliability of sonography, increases speciﬁcity and allows
better differentiation between benign and malignant focal ﬁnd-
ings, particularly between Breast Imaging-Recording and Data
System (BI-RADS) US 3 and BI-RADS-US 4. Therefore, the
number of false-positive ﬁndings in breast diagnostics was able
to be reduced by using elastography (10–13).
The current prospective study aimed to evaluate the diag-
nostic yield of mammography, B-mode ultrasound, ultrasound
elastography and color Doppler used alone or in combination
for differentiating breast lesions as benign or malignant in
comparison with histopathological examination of excisional
biopsy.
2. Patients and methods
The current study was conducted at Departments of
Radiodiagnosis and General Surgery, Benha University
Hospital since June 2011 till Feb 2013. The study included
60 female patients who attended the General Surgery outpa-
tient clinic with breast mass that on clinical examination was
suspicious to be malignant and who were admitted for open
excisional biopsy.
After consent taken from all, patients underwent radiolog-
ical workup included mammographic examination, B-mode
ultrasonography, Doppler assessment and ultrasound elastog-
raphy. Mammographic examinations were performed based
on the standard cranio-caudal and medio-lateral oblique pro-
jections of each breast and according to the American
College of Radiology (ACR) classiﬁcation breast density was
classiﬁed into 4 groups: 1. predominantly fat; 2. fat with someﬁbroglandular tissue; 3. heterogeneously dense; and 4. extre-
mely dense. Speciﬁc lesion descriptions included mass descrip-
tion as regards size, location, shape and margin; calciﬁcations
description concerned morphology, distribution and location;
architectural distortion, associated ﬁndings and lymph nodes
assessment regarding number, size and morphology. Then,
an overall assessment with BI-RADS category was assigned
for each patient (14).
Using B-mode imaging, lesion size was determined as the
maximal diameter of the lesion. The detected lesions were
described concerning shape, orientation, margin, lesion bound-
ary, echotexture, and acoustic transmission and the presence of
calciﬁcations was also documented. Lesions with ovoid, round
or macro-lobulated shape, parallel orientation to the skin, cir-
cumscribed margin, abrupt interface to the normal parench-
yma were categorized as probably benign (BI-RADS
category 3). Lesions with irregular shape, not parallel to skin,
lacking circumscribed margin, showing thick echogenic halo,
complex ehcotexture, posterior acoustic shadowing or com-
bined pattern with the presence of micro-calciﬁcations were
considered as malignant criteria. In the presence of one malig-
nant criterion, lesion was considered as suspicious for malig-
nancy (BI-RADS category 4) and if more than one criterion
was present, lesion was considered as highly suspicious for
malignancy (BI-RADS category 5).
Lesions were evaluated qualitatively according to their
power Doppler ultrasound (PDUS) properties and quantita-
tively with spectral evaluation depending on the resistive index
(RI). Qualitative categorization was based on the number and
shape of the vessels (15): no vascularity in the mass
(score = 0), one circumferential or central vessel was found
in the mass (score = 1) and two or more circumferential or
central vessels or a penetrating vessel was found in the mass
(score = 2). Quantitative analysis included hyper-
vascularization, penetration of the vessels into the mass,
branching-disordered course and RI values >0.85 which were
considered as probable malignant criteria (16).
All elasticity images were obtained with a system that con-
sisted of a digital US scanner (EUB-6500; Hitachi Medical,
Tokyo, Japan). The US probe was a 7.5-MHz liner electronic
probe (EUP-L53; Hitachi Medical). The top of the region of
interest (ROI) included subcutaneous fat and the bottom
included the pectoral muscles and lateral borders were set
>5 mm from the lesion’s boundary. Depending on the magni-
tude of the strain, the scale ranged from red for components
with greatest strain indicating softest components to blue for
those with no strain indicating hardest components and green
indicated average strain in the ROI. The color pattern in the
detected lesions was evaluated on the basis of ﬁve-point elastic-
ity score proposed by Itoh et al. (17): the entire lesion was
evenly shaded in green (score = 1) indicated even strain for
the entire hypoechoic lesion. The lesion had a mosaic pattern
of green and blue (score = 2) indicated strain in most of the
lesion with some areas of no strain. The peripheral part of
lesion was green and the central part was blue (score = 3) indi-
cated strain at the periphery of the hypoechoic lesion, with
sparing of the center of the lesion. The entire lesion was blue,
but its surrounding area was not included (score = 4) indi-
cated no strain in the entire hypoechoic lesion. Both the entire
hypoechoic lesion and its surrounding area were blue
(score = 5) indicated no strain in the entire hypoechoic lesion
or in the surrounding area. The strain index, deﬁned as the fat
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Fig. 1 Mean (±SD) of Doppler color scoring of lesions
categorized according to pathological diagonsis.
Ultrasound elastography improves differentiation 1233to mass strain ratio (B/A ratio) that indicated mass stiffness,
was automatically calculated.
The likelihood of malignancy was established based on
combined B-mode US, Doppler and Ultrasound
Elastography. The likelihood of malignancy category was
changed from BI-RADS 4 or 5 (biopsy recommendation) to
BI-RADS 3 (follow-up recommendation) when the elasticity
score was 0, 1 or 2 or Doppler score was achieved. The likeli-
hood of malignancy category from BI-RADS 3 (follow-up rec-
ommendation) to BIRADS 4 or 5 (biopsy recommendation)
when the elasticity score was 4 or 5 or Doppler score was 2
or more was achieved (18).
All patients underwent excisional biopsy and the results of
pathologic examination of the obtained specimen were used as
gold standard for comparison of the results of imaging studies.
The results were statistically analyzed using SPSS software
statistical computer package version 17 for quantitative data.
Statistical presentation and analysis of the present study were
conducted, using, relative operating characteristics (ROC)
curve and area under the curve (AUC) to know the clinical
signiﬁcance.
3. Results
The study included 60 women with mean age of 43.6 ± 8.2;
range: 32–55 years. Clinically, all patients presented by lump,
but 5 patients had additional symptoms: two patients had nip-
ple discharge, another two patients had pain (3.3%) and one
patient presented with nodulations (3.3%). No patient had
bilateral lesions. Histopathological examination of excised
biopsy detected 42 benign lesions, while 18 lesions were
malignant.
Mammographic examination deﬁned 36 patients had dense
glandular breast (ACR pattern III/IV), while the remaining 24
patients had fatty breast parenchyma (ACR pattern I/II).
Comparison versus histopathological results deﬁned 11 malig-
nant lesions among those had dense glandular parenchyma
and 7 malignant lesions among patients those had fatty breast
parenchyma. BI-RADS categorization of mammographic ﬁnd-
ings showed that 41 lesions were categorized as BI-RADS cat-
egory 3; 12 lesions were categorized as BI-RADS category 4;
and 7 lesions were categorized as BI-RADS category 5. Only
4 BI-RADS category 3 lesions were malignant and 37 were
benign, 7 BI-RADS category 4 lesions were malignant and 5Table 1 Mammographic and ultrasonographic ﬁndings of 60 breas
Benign
Histopathology 42 (70%)
Mammography Dense glandular breast 25 (69.4%)
Fatty parenchyma 17 (70.8%)
BI-RADS category 3 37 (90.2%)
4 5 (41.7%)
5 0
Ultrasonography Lesion diameter (mm) 22.9 ± 9.2 (8–40)
BI-RADS category 3 32 (86.5%)
4 9 (52.9%)
5 1 (16.7%)
Data are presented as numbers and mean ± SD; ranges & percentages owere benign and the 7 BI-RADS category 5 lesions were malig-
nant with signiﬁcantly (X2 = 21.336, p= 0.001) high fre-
quency of malignancy among BI-RADS categories 4 and 5
lesions compared to the frequency of benign lesions (Table 1).
Mean maximal diameter of studied lesions as estimated by
US examination was 21.9 ± 8.8; range: 8–40 mm. Mean diam-
eter of benign lesions was 22.9 ± 9.2; range: 8–40 mm, while
mean maximal diameter of malignant lesions was 19.8 ± 7.7;
range: 9–34 mm, with non-signiﬁcantly (p> 0.05) wider diam-
eter of benign lesions compared to malignant lesions. BI-
RADS categorization of ultrasonographic ﬁndings showed
that 37 lesions were categorized as BI-RADS category 3; 17
lesions were categorized as BI-RADS category 4; 6 lesions
were categorized as BI-RADS category 5. Only 5 BI-RADS
category 3 lesions were malignant and 32 were benign, eight
BI-RADS category 4 lesions were malignant and 9 were benign
and 5 of the 6 BI-RADS category 5 lesions were malignant,
while only one of the 6 BI-RADS category 5 lesions was
benign with signiﬁcantly (X2 = 9.635, p= 0.003) high fre-
quency of malignancy among BI-RADS categories 4 and 5
lesions compared to the frequency of benign lesions (Table 1).
Doppler color score 0 was noted in 8 cases (13.3%), score 1
in 30 cases (50%), and score 2 in 22 cases (36.7%). Mean resis-
tive index (RI) value for benign lesions was 0.56 ± 0.12; range:ts compared to histopathological diagnosis.
Malignant Total Statistical signiﬁcance
18 (30%) 60 (100%)
11 (30.6%) 36 (100%)
7 (29.2%) 24 (100%)
4 (9.8%) 41 (100%)
7 (58.3%) 12 (100%) X2 = 21.336, p= 0.001
7 (100%) 7 (100%)
19.8 ± 7.7 (9–34) 21.9 ± 8.8 (8–40) Z= 0.881, p> 0.05
5 (13.5%) 37 (100%)
8 (47.1%) 17 (100%) X2 = 9.635, p= 0.003
5 (83.3%) 6 (100%)
f corresponding total are in parenthesis.
Table 2 Color Doppler ﬁndings.
Data Findings
Color score Zero 8 (13.3%)
One 30 (50%)
Two 22 (36.7%)
Resistive index (RI) Benign 0.56 ± 0.12 (0.44–0.97)
Malignant 0.86 ± 0.18 (0.5–1.2)
Diagnostic yield at cutoﬀ point of 0.85 False negative cases 4
False positive cases 9
Sensitivity 77.8%
Speciﬁcity 78.6%
Data are presented as numbers, mean ± SD and percentages; ranges and percentages are in parenthesis.
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Fig. 2 Mean (±SD) of US elastography scoring of lesions
categorized according to pathological diagnosis.
Table 3 Ultrasound elastographic ﬁndings.
Data Findings
Ultrasound elastography score One 13 (21.7%)
Two 20 (33.3%)
Three 7 (11.7%)
Four 12 (20%)
Five 8 (13.3%)
Strain ratio Benign 3.21 ± 1.65 (1–7)
Malignant 8.31 ± 4.14 (3–15)
Data are presented as numbers, mean ± SD and percentages;
ranges and percentages are in parenthesis.
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Fig. 3 Frequency of false results of each diagonstic modality.
1234 A. Elkharbotly, H.M. Farouk0.44–0.97, while mean RI value for malignant lesions was
0.86 ± 0.18; range: 0.5–1.2. Mean RI value was signiﬁcantly
(Z= 3.421, p= 0.001) higher with malignant lesions com-
pared to benign lesions, (Fig. 1). Considering RI at 0.85 as cut-
off point for differentiation between benign and malignant
lesions, RI missed 4 malignant lesions (False negative) with
RI < 0.85 and over-diagnosed 9 benign lesions with
RI > 0.85 (False positive) so could differentiate between
benign and malignant lesions with sensitivity rate of 77.8%
and speciﬁcity rate of 78.6% (Table 2).Ultrasound elastography scoring showed that 13 lesions
were scored 1, 21 lesions were scored 2, 21 lesions were scored
3, 12 lesions were scored 4 and 8 lesions were scored 5. The
mean strain ratio of the benign lesions was 3.21 ± 1.65; range:
1–7, while that for malignant lesions was 8.31 ± 4.14; range:
3–15. Strain ratio was signiﬁcantly (Z= 3.012, p= 0.003)
higher for malignant lesions compared to benign lesions
(Table 3, Fig. 2).
Ultrasound examination (b-mode US) showed the higher
percentage of fallacies where it showed 15 misdiagnoses for a
rate of 25%; 5 were false negative and 10 false positive.
Similarly, US Doppler showed 13 misdiagnoses for a rate of
21.7%; 4 were false negative and 9 were false positive.
Mammography showed 9 fallacies for a rate of 15%; 4 were
false negative and 5 were false positive. Ultrasound elastogra-
phy showed 8 fallacies for a rate of 13.3%; 3 were false nega-
tive and 5 were false positive. Combined ultrasound
elastography and Doppler showed the least fallacy rate of
11.7%; 2 were false negative and 5 were false positive (Fig. 3).
Evaluation of test validity characters of applied diagnostic
modality alone or in combination for diagnosis of breast can-
cer showed the combined use of US and UE provided better
diagnostic yield than US and Doppler with higher percentage
of all characters that superseded the use of any modality alone.
However, the combined use of US, UE and Doppler improved
the diagnostic yield with high sensitivity and speciﬁcity rates
and high NPV of 95% (Table 4, Fig. 4).
Table 4 Test validity characters of applied diagnostic modalities for diagnosis of breast cancer.
Sensitivity (%) Speciﬁcity (%) PPV (%) NPV (%) Accuracy (%)
Mammography 77.8 88.1 73.7 90.2 85
US 72.2 76.2 56.5 86.5 75
US + Doppler 77.8 78.6 60.9 89.2 78.3
US + UE 83.3 88.1 75 92.5 86.7
US + UE+Doppler 88.9 88.4 76.2 95 88.5
Data are presented as percentages; US: Ultrasound; UE: Ultrasound elastography; PPV: positive predictive value; NPV: negative predictive
value.
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Fig. 4 Senstivity and speciﬁcity of applied diagnostic modalities
for diagnosis of breast cancer.
Table 5 ROC curve analysis of the obtained results of the
applied diagnostic modalities for diagnosis of breast cancer.
AUC Std
Error
Sig. 95% CI
Lower Upper
Mammography 0.831 0.064 0.0009 0.705 0.957
US 0.745 0.072 =0.003 0.604 0.886
US + Doppler 0.784 0.068 =0.001 0.652 0.917
US + UE 0.859 0.059 0.0005 0.744 0.973
US + UE+Doppler 0.886 0.052 0.0001 0.785 0.988
AUR: Area under curve; Std Error: standard error; Sig.: signiﬁ-
cance; CI: conﬁdence interval.
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Fig. 5 ROC curve analysis of applied diagnostic procedures for
diagnosis of malignant breast cancer.
Ultrasound elastography improves differentiation 1235Analysis of the obtained results using ROC curve analysis
assured the high diagnostic yield of combination of diagnostic
modality with high AUC for the combined use of US, UE and
Doppler, followed by the combined use of US and UE, then
mammography, the combined use of US and Doppler and
lastly US, (Table 5, Fig. 5).
4. Discussion
The current study showed high diagnostic yield of using com-
bined diagnostic modalities including B-mode US, US
elastography and color Doppler; such combination couldexclude the presence of cancer by NPV of 95% and accuracy
and speciﬁcity rates of about 90%. These data indicated the
possibility of using such combination for mass screening espe-
cially for those at high-risk for developing cancer.
Moreover, ROC curve analysis of the obtained data deﬁned
such combination as the most speciﬁc predictors
(AUC= 0.886) for the presence of cancer.
The US elastography showed sensitivity and speciﬁcity
rates of 83.3% and 88.1%, respectively and NPV of 92.5%
and accuracy rate for diagnosis of malignancy of 86.7%.
ROC curve analysis deﬁned UE as the highly speciﬁc single
test for diagnosis of breast malignancy with AUC= 0.859.
The reported high diagnostic yield of the combined methodol-
ogy could be attributed to the high diagnostic yield of UE
which improved the diagnostic yield of both conventional B-
mode US and color Doppler when used in combination.
In support of the obtained results Mansour and Omar (19)
found UE, using both qualitative and quantitative methods
can improve the performance of conventional B-mode ultra-
sound and enhance its speciﬁcity and accuracy in the diagnosis
Fig. 6 A 34 years old woman presented with clinically right breast mass, Mammography shows: ACR pattern 4; descriptive criteria
include macro-lobulated rounded well deﬁned dense right breast mass; BI-RADS 3. B-mode U/S showed lobulated antiparallel oval
shaped, rather well circumscribed, hypo-echoic mass with marginal shadowing. Lesion Size: 13 · 8 mm. BIRADS: 3. Doppler Color score:
0. U/S elastography: UE score 1 and SR: 1.5. Final combined (B-mode US, Doppler US & UE) diagnosis: typical ﬁbroadenoma (Follow-
up recommended). Pathological diagnosis: typical ﬁbroadenoma.
Fig. 7 A 38 years old woman presented with clinically right breast mass, Mammography shows: ACR pattern 2; descriptive criteria:
macro-lobulated dense well deﬁned right breast mass; BI-RADS 3. B-mode U/S showed lobulated antiparallel hypoechoic mass with well-
deﬁned border. Lesion Size: 20 · 12 mm. BIRADS: 4-a. Doppler Color score: 1 & RI: 0.69. U/S elastography: UE score 1 and SR: 2.4.
Final combined (B-mode US, Doppler US & UE) diagnosis: Probably benign (Follow-up recommended). Pathological diagnosis:
Papilloma.
1236 A. Elkharbotly, H.M. Faroukof questionable (BI-RADS categories 3 and 4) breast lesions.
Fischer et al. (20) documented that strain ratio calculation
contributes to the standardization of sonoelastography with
high sensitivity and allows signiﬁcant differentiation between
benign and malignant breast lesions with a higher speciﬁcity
compared to B-mode, subjective evaluation of elastography
and mammography.Zhi et al. (21) reported a highly signiﬁcant correlation
between the elastogram color distribution and the percentage
of malignant lesions with speciﬁcity, sensitivity, and accuracy
rates of 86.4%, 80.8%, and 83.5%, respectively which were
higher than US with AUC= 0.86. Alhabshi et al. (22) found
the sensitivity and speciﬁcity of combined UE and conven-
tional US were signiﬁcantly higher than those of conventional
Fig. 9 A 44 years old woman presented with clinically left breast mass, Mammography shows: ACR pattern 1; descriptive criteria
include well-deﬁned oval shaped left breast mass nipple retraction, and intraductal extension; BI-RADS 4c. B-mode U/S showed a rather ill-
deﬁned anti-parallel rounded hypo-echoic mass. Lesion Size: 18 · 15 mm. BIRADS: 4c. Doppler Color score: 2 & RI: 0.98. U/S
elastography: UE score 2 and SR: 3.5. Final combined (B-mode US, Doppler US & UE) diagnosis: Probably malignant (Biopsy
recommended). Pathological diagnosis: Colloid carcinoma.
Fig. 8 A 50 years old woman presented with clinically left breast mass, Mammography shows: ACR pattern 2; descriptive criteria
include an irregular micro-lobulated border .dense left breast mass with nipple retraction, and intraductal extension; BI-RADS 5. B-mode
U/S showed lobulated antiparallel, rather ill-deﬁned, hypo-echoic mass with peripheral shadowing. Lesion Size: 20 · 15 mm. BIRADS:
4C. Doppler Color score: 2 & RI: 0.85. U/S elastography: UE score 4 and SR: 10.1. Final combined (B-mode US, Doppler US & UE)
diagnosis: mostly malignant (Biopsy recommended). Pathological diagnosis: Invasive duct carcinoma.
Ultrasound elastography improves differentiation 1237US alone and the assessment with strain ratio and width ratio
in UE were the most useful parameters in differentiating
between benign and malignant breast lesions and concluded
that this combined technique had the best results in detectingcarcinoma and could reduce the need of unnecessary biopsy
for benign lesions with indeterminate or equivocal features.
Zhang et al. (23) evaluated and compared diffuse optical
tomography (DOT), ultrasound elastography (UE) and
Fig. 10 A 53 years old woman presented with clinically left breast mass, Mammography shows: ACR pattern 3; descriptive criteria
include an oval macro-lobulated dense well deﬁned left breast mass; BI-RADS 3. B-mode U/S showed an oval parallel lobulated hypo-
echoic focal lesion. Lesion Size: 35 · 18 mm. BIRADS: 3. Doppler Color score: 2 & RI: 0.5 U/S elastography: UE score 2 and SR: 1.7.
Final combined (B-mode US, Doppler US & UE) diagnosis: Probably benign (Follow-up recommended). Pathological diagnosis: Invasive
duct carcinoma.
1238 A. Elkharbotly, H.M. Faroukmammography in differentiating breast tumors, found UE was
the most speciﬁc and DOT and UE were more accurate than
mammography and concluded that UE and DOT were supe-
rior to conventional mammography in terms of both speciﬁcity
and accuracy and improve the speciﬁcity and accuracy of
breast cancer diagnosis, and combining the two modalities
improves the diagnostic value (Figs. 6 and 7).
The current study reported a signiﬁcantly higher mean
strain ratio for malignant lesions compared to benign lesions.
In line with this ﬁnding, Zhao et al. (24) found the mean strain
ratios were signiﬁcantly higher of malignant than benign
lesions and that in the 5-point scoring, sonoelastography had
84.2% sensitivity, 84.6% speciﬁcity, 84.5% accuracy, 70.6%
positive predictive value and 92.4% negative predictive value
and concluded that the 5-point scoring system and strain ratio
have similar diagnostic performance, and the strain ratio could
be more objective to differentiate the masses when those
masses were difﬁcult to be judged by using 5-point scoring sys-
tem in sonoelastographic images. Sayed et al. (25) reported
that the strain ratio values for the malignant breast masses
were signiﬁcantly higher compared to benign masses and con-
cluded that the proposed elastographic techniques can be used
as a noninvasive quantitative characterization tool for breast
cancer, with the capability of visualizing and separating the
masses in a three dimensional space and thus may reduce the
number of unnecessary painful breast biopsies (Figs. 8 and 9).
Mammography showed high sensitivity rate for detecting
breast cancer in comparison with US alone or color Doppler
alone; a ﬁnding indicating its applicability as a single screening
test and so could be used as a sole screening test wherever, the
facilities are deﬁcient. However, the main disadvantage of
dependence on mammography as the sole test is its high false
positive rate inducing high rate of malignant over-diagnosis.These data are in accordance with Kalager et al. (26) who doc-
umented that mammography screening entails a substantial
amount of over-diagnosis ranged between 18% and 25% of
screened women. Coldman and Phillips (27) documented that
the use of mammography screening in older women has an
increased risk of over-diagnosis and the estimation of over-
diagnosis from observational data is complex and subject to
many inﬂuences so it should be considered in screening deci-
sions (Fig. 10).
It could be concluded that combined use of B-mode US,
UE and color Doppler achieved high NPV of 95% thus allow-
ing sparing of unnecessary invasive diagnostic procedures. UE
could be used as a sole diagnostic test with high sensitivity and
speciﬁcity and improved the diagnostic yield of other tests
when used in combination. Wherever, other diagnostic proce-
dures are lacking mammography could be used as a screening
test for its high sensitivity despite the malignant over-
diagnosis.
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